Aubagio Umoja wa Ulaya - Kiswidi - EMA (European Medicines Agency)

aubagio

sanofi winthrop industrie - teriflunomide - multipel skleros - selektiva immunsuppressiva medel - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Bencium 500 mg/800 IE Tuggtablett Uswidi - Kiswidi - Läkemedelsverket (Medical Products Agency)

bencium 500 mg/800 ie tuggtablett

consilient health limited - kalciumkarbonat; kolekalciferol - tuggtablett - 500 mg/800 ie - sorbitol hjälpämne; aspartam hjälpämne; kolekalciferol 800 ie aktiv substans; kalciumkarbonat 1250 mg aktiv substans; isomalt hjälpämne; xylitol hjälpämne; sackaros hjälpämne

Axhidrox 2,2 mg/pumpning Kräm Uswidi - Kiswidi - Läkemedelsverket (Medical Products Agency)

axhidrox 2,2 mg/pumpning kräm

dr. august wolff gmbh & co arzneimittel - glykopyrroniumbromid - kräm - 2,2 mg/pumpning - propylenglykol hjälpämne; bensylalkohol hjälpämne; glykopyrroniumbromid 2,7 mg aktiv substans; cetostearylalkohol hjälpämne

Melatonin Evolan 1 mg/ml Oral lösning Uswidi - Kiswidi - Läkemedelsverket (Medical Products Agency)

melatonin evolan 1 mg/ml oral lösning

evolan pharma ab - melatonin - oral lösning - 1 mg/ml - bensylalkohol hjälpämne; melatonin 1 mg aktiv substans; propylenglykol hjälpämne

Teriflunomide Mylan Umoja wa Ulaya - Kiswidi - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - multipel skleros, skovvis förlöpande - immunsuppressiva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord Umoja wa Ulaya - Kiswidi - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - multipel skleros, skovvis förlöpande - immunsuppressiva, selektiva immunsuppressiva - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Teriflunomide Newbury 14 mg Filmdragerad tablett Uswidi - Kiswidi - Läkemedelsverket (Medical Products Agency)

teriflunomide newbury 14 mg filmdragerad tablett

newbury pharmaceuticals ab - teriflunomid - filmdragerad tablett - 14 mg - teriflunomid 14 mg aktiv substans; laktosmonohydrat hjälpämne

Teriflunomide Sandoz 14 mg Filmdragerad tablett Uswidi - Kiswidi - Läkemedelsverket (Medical Products Agency)

teriflunomide sandoz 14 mg filmdragerad tablett

sandoz a/s - teriflunomid - filmdragerad tablett - 14 mg - allurarött ac aluminiumlack hjälpämne; glycerol hjälpämne; laktosmonohydrat hjälpämne; teriflunomid 14 mg aktiv substans

Teriflunomide STADA 14 mg Filmdragerad tablett Uswidi - Kiswidi - Läkemedelsverket (Medical Products Agency)

teriflunomide stada 14 mg filmdragerad tablett

stada arzneimittel ag - teriflunomid - filmdragerad tablett - 14 mg - teriflunomid 14 mg aktiv substans; laktosmonohydrat hjälpämne

Teriflunomid Zentiva 14 mg Filmdragerad tablett Uswidi - Kiswidi - Läkemedelsverket (Medical Products Agency)

teriflunomid zentiva 14 mg filmdragerad tablett

zentiva k.s. - teriflunomid - filmdragerad tablett - 14 mg - teriflunomid 14 mg aktiv substans; laktosmonohydrat hjälpämne